Trading Report: Today, KBC Group NV invests in HCP Inc. (HCP) Shares

Today, KBC Group NV invests in HCP Inc. (HCP) Shares

KBC Group NV increased its position in shares of HCP Inc. (NYSE:HCP) by 37.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 309,840 shares of the real estate investment trust’s stock after buying an additional 84,015 shares during the period. KBC Group NV owned approximately 0.07% of HCP worth $11,759,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of HCP. LGT Capital Partners LTD. raised its stake in HCP by 10.5% in the second quarter. LGT Capital Partners LTD. now owns 441,440 shares of the real estate investment trust’s stock worth $15,618,000 after buying an additional 41,790 shares during the last quarter. Chevy Chase Trust Holdings Inc. raised its stake in HCP by 1.3% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 401,212 shares of the real estate investment trust’s stock worth $14,195,000 after buying an additional 5,206 shares during the last quarter. Exxonmobil Investment Management Inc. TX raised its stake in HCP by 6.7% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 120,906 shares of the real estate investment trust’s stock worth $4,278,000 after buying an additional 7,560 shares during the last quarter. DNB Asset Management AS increased its position in shares of HCP by 2.7% in the second quarter. DNB Asset Management AS now owns 37,966 shares of the real estate investment trust’s stock valued at $1,343,000 after buying an additional 1,000 shares during the period. Finally, British Columbia Investment Management Corp increased its position in shares of HCP by 4.9% in the second quarter. British Columbia Investment Management Corp now owns 228,975 shares of the real estate investment trust’s stock valued at $8,101,000 after buying an additional 10,655 shares during the period. 91.72% of the stock is currently owned by hedge funds and other institutional investors.

HCP Inc. (NYSE:HCP) traded down 0.85% during trading on Friday, reaching $29.26. 2,109,091 shares of the company’s stock were exchanged. The company’s market capitalization is $13.69 billion. The company’s 50-day moving average is $30.99 and its 200-day moving average is $32.85. HCP Inc. has a 1-year low of $22.87 and a 1-year high of $36.82.

HCP (NYSE:HCP) last posted its quarterly earnings data on Tuesday, November 1st. The real estate investment trust reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. HCP had a negative net margin of 1.16% and a negative return on equity of 0.32%. The firm earned $654.30 million during the quarter, compared to analyst estimates of $634.11 million. During the same quarter last year, the business posted $0.79 EPS. Equities research analysts expect that HCP Inc. will post $2.74 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 25th. Investors of record on Thursday, November 10th will be paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 5.06%. The ex-dividend date of this dividend is Tuesday, November 8th. HCP’s dividend payout ratio is -1,850.00%.

Several research analysts have weighed in on HCP shares. Zacks Investment Research upgraded HCP from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a report on Wednesday, October 5th. Vetr upgraded HCP from a “hold” rating to a “buy” rating and set a $36.58 price target for the company in a report on Wednesday, October 26th. Mizuho upgraded HCP from a “neutral” rating to a “buy” rating and boosted their price target for the company from $31.00 to $32.00 in a report on Monday. Argus reiterated a “hold” rating on shares of HCP in a report on Sunday, September 18th. Finally, Wells Fargo & Co. reiterated a “hold” rating on shares of HCP in a report on Sunday, September 4th. Four equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $34.33.

In related news, insider Darren A. Kowalske sold 2,250 shares of the firm’s stock in a transaction that occurred on Wednesday, August 31st. The shares were sold at an average price of $39.20, for a total value of $88,200.00. Following the completion of the transaction, the insider now owns 9,793 shares of the company’s stock, valued at approximately $383,885.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas D. Kirby sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $40.24, for a total transaction of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by corporate insiders.

HCP Company Profile

Related posts

Leave a Comment